UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HBI
1401
DELISTED
Hanesbrands
HBI
| $2.99M | ﹤0.01% |
568,024
-17,981
| -3% | -$113K |
|
1402
Plexus
PLXS
$7.16B
| $2.98M | ﹤0.01% |
30,578
+3,494
| +13% | +$350K |
|
|
SEM
1403
DELISTED
Select Medical
SEM
| $2.98M | ﹤0.01% |
214,101
-3,172
| -1% | -$46.7K |
|
1404
Opendoor
OPEN
$3.38B
| $2.98M | ﹤0.01% |
1,750,479
-1,128,742
| -39% | -$1.86M |
|
1405
Itron
ITRI
$4.49B
| $2.98M | ﹤0.01% |
53,661
+2,182
| +4% | +$120K |
|
1406
Alight
ALIT
$394M
| $2.94M | ﹤0.01% |
15,970
+558
| +4% | +$102K |
|
|
RVNC
1407
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.93M | ﹤0.01% |
90,914
+11,928
| +15% | +$372K |
|
1408
Mercury Systems
MRCY
$6.52B
| $2.92M | ﹤0.01% |
57,130
-4,011
| -7% | -$203K |
|
1409
Omnicell
OMCL
$1.7B
| $2.91M | ﹤0.01% |
49,578
+4,051
| +9% | +$223K |
|
1410
Moelis & Co
MC
$4.72B
| $2.89M | ﹤0.01% |
+75,227
| New | +$3.23M |
|
1411
Corcept Therapeutics
CORT
$12.3B
| $2.89M | ﹤0.01% |
133,351
+3,447
| +3% | +$75.6K |
|
|
ESGR
1412
DELISTED
Enstar Group
ESGR
| $2.88M | ﹤0.01% |
12,444
+715
| +6% | +$169K |
|
1413
Leslie's
LESL
$10.4M
| $2.88M | ﹤0.01% |
13,089
+988
| +8% | +$257K |
|
|
CIVI
1414
DELISTED
Civitas Resources
CIVI
| $2.87M | ﹤0.01% |
42,047
-952
| -2% | -$61.7K |
|
|
B
1415
DELISTED
Barnes Group Inc.
B
| $2.86M | ﹤0.01% |
+71,113
| New | +$2.99M |
|
1416
CVB Financial
CVBF
$3.97B
| $2.86M | ﹤0.01% |
171,689
-8,519
| -5% | -$194K |
|
1417
Alarm.com
ALRM
$2.79B
| $2.86M | ﹤0.01% |
+56,901
| New | +$2.93M |
|
1418
MYR Group
MYRG
$5.14B
| $2.84M | ﹤0.01% |
22,575
+1,331
| +6% | +$143K |
|
|
PRFT
1419
DELISTED
Perficient Inc
PRFT
| $2.84M | ﹤0.01% |
39,399
+3,183
| +9% | +$232K |
|
1420
Nu Skin
NUS
$250M
| $2.84M | ﹤0.01% |
72,279
+3,767
| +5% | +$157K |
|
1421
Alamo Group
ALG
$2.06B
| $2.84M | ﹤0.01% |
+15,428
| New | +$2.54M |
|
|
GMS
1422
DELISTED
GMS Inc
GMS
| $2.84M | ﹤0.01% |
49,055
+13,565
| +38% | +$768K |
|
|
ENV
1423
DELISTED
ENVESTNET, INC.
ENV
| $2.84M | ﹤0.01% |
48,326
+2,947
| +6% | +$183K |
|
1424
NETSCOUT
NTCT
$2.81B
| $2.84M | ﹤0.01% |
98,956
+7,430
| +8% | +$222K |
|
1425
Frontdoor
FTDR
$5.78B
| $2.83M | ﹤0.01% |
101,544
+5,285
| +5% | +$140K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.